Crossmark Global Holdings, Inc. Alkermes Plc. Transaction History
Crossmark Global Holdings, Inc.
- $5.49 Billion
- Q4 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 10,819 shares of ALKS stock, worth $359,298. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,819
Previous 10,886
0.62%
Holding current value
$359,298
Previous $304,000
2.3%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$967 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$614 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$407 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$293 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$251 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.45B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...